Lung cancer drug therapy in Hungary – 3-year experience

Figures & data

Figure 1 Lung cancer (ICD-10 codes C33-C34), European age-standardized mortality rates, EU-27 countries, 2008 estimates.

Note: Adapted from Cancer Research UK, http://www.cancerresearchuk.org/cancer-info/cancerstats/types/lung/mortality/. Accessed January, 2014.¹
Abbreviation: ICD, International Classification of Diseases.

Figure 2 Histologic distribution of lung cancer in 2002 (n=6,361), 2006 (n=6,519), and 2011 (n=6,205).

Abbreviations: ADC, adenocarcinoma; SCC, squamous cell carcinoma; SCLC, small-cell lung cancer; LCC, large-cell carcinoma.

Figure 3 Stages of lung cancer at the time of diagnosis by the type of discovery (2011, n=6,205).

Figure 4 Therapeutic modalities (%) in new lung cancer cases by the type of discovery.

Notes: Type of discovery: (A) complaints, (B) screening (2011, n=6,205).

Figure 5 Lung cancer: number of patients receiving different therapies (January 1, 2008 to December 21, 2010.)

Figure 6 Lung cancer: number of patients who received chemotherapy and/or drug therapy in any treatment lines.

Figure 7 Lung cancer: percentage of patients receiving first-line treatment.

Figure 8 Lung cancer: percentage of patients treated with docetaxel in different therapy lines.

Note: We considered a therapy “old” when treatments started before 2008.

Figure 9 Lung cancer: percentage of patients treated with pemetrexed in different therapy lines.

Note: We considered a therapy “old” when treatments started before 2008.

Figure 10 Lung cancer: percentage of patients treated with erlotinib in different therapy lines.

Note: We considered a therapy “old” when treatments started before 2008.

Cancer Research UKLung cancer mortality statistics2014 Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/lung/mortalityAccessed January 3, 2014

 Google Scholar